(UGI) UGI - Ratings and Ratios
Propane, Natural Gas, Electricity, LPG, Midstream
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.25% |
| Yield on Cost 5y | 5.07% |
| Yield CAGR 5y | 2.39% |
| Payout Consistency | 74.9% |
| Payout Ratio | 57.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 17.8% |
| Value at Risk 5%th | 26.9% |
| Relative Tail Risk | -7.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.28 |
| Alpha | 25.35 |
| CAGR/Max DD | 0.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.398 |
| Beta | 0.427 |
| Beta Downside | 0.378 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.55% |
| Mean DD | 25.89% |
| Median DD | 33.00% |
Description: UGI UGI January 06, 2026
UGI Corporation (NYSE: UGI) is a diversified energy-distribution company operating four business segments-Utilities, Midstream & Marketing, UGI International, and AmeriGas Propane-that together serve roughly 801 million end-users across residential, commercial, industrial, agricultural, motor-fuel and wholesale markets.
Through its Utilities arm, UGI delivers natural gas to about 694 k customers via 12,700 mi of pipelines in eastern and central Pennsylvania and supplies electricity to roughly 62.9 k customers through 2,700 mi of lines and 14 substations. The Midstream & Marketing segment handles LPG (propane) logistics, storage, and vaporization, while AmeriGas is the largest U.S. propane retailer, serving both residential and commercial accounts.
Key operating metrics (FY 2023) include total revenue of ≈ $2.5 billion, adjusted EBITDA of $300 million (≈ 12 % margin), and a pipeline utilization rate of roughly 78 %. The business is sensitive to seasonal propane demand, natural-gas price volatility, and regulatory changes affecting utility rates and emissions standards.
Investors should watch macro drivers such as U.S. residential heating demand, the pace of natural-gas price rebounds after the 2023-24 winter, and capital-expenditure cycles for pipeline upgrades, which historically influence UGI’s cash-flow stability.
For a deeper, data-driven analysis of UGI’s valuation dynamics, consider exploring the detailed metrics and scenario models on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 678.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.03 > 1.0 |
| NWC/Revenue: -2.95% < 20% (prev -5.67%; Δ 2.72% < -1%) |
| CFO/TA 0.15 > 3% & CFO 2.36b > Net Income 678.0m |
| Net Debt (6.80b) to EBITDA (1.66b): 4.10 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (221.4m) vs 12m ago 2.73% < -2% |
| Gross Margin: 42.12% > 18% (prev 0.45%; Δ 4168 % > 0.5%) |
| Asset Turnover: 47.70% > 50% (prev 47.75%; Δ -0.05% > 0%) |
| Interest Coverage Ratio: 2.67 > 6 (EBITDA TTM 1.66b / Interest Expense TTM 411.0m) |
Altman Z'' 1.59
| A: -0.01 (Total Current Assets 1.77b - Total Current Liabilities 1.98b) / Total Assets 15.46b |
| B: 0.22 (Retained Earnings 3.33b / Total Assets 15.46b) |
| C: 0.07 (EBIT TTM 1.10b / Avg Total Assets 15.28b) |
| D: 0.47 (Book Value of Equity 5.04b / Total Liabilities 10.68b) |
| Altman-Z'' Score: 1.59 = BB |
Beneish M -3.20
| DSRI: 0.88 (Receivables 714.0m/801.0m, Revenue 7.29b/7.21b) |
| GMI: 1.06 (GM 42.12% / 44.68%) |
| AQI: 0.96 (AQ_t 0.30 / AQ_t-1 0.31) |
| SGI: 1.01 (Revenue 7.29b / 7.21b) |
| TATA: -0.11 (NI 678.0m - CFO 2.36b) / TA 15.46b) |
| Beneish M-Score: -3.20 = AA |
ValueRay F-Score (Strict, 0-100) 51.07
| 1. Piotroski: 3.0pt |
| 2. FCF Yield: 2.55% |
| 3. FCF Margin: 5.35% |
| 4. Debt/Equity: 1.58 |
| 5. Debt/Ebitda: 4.10 |
| 6. ROIC - WACC: 4.44% |
| 7. RoE: 14.09% |
| 8. Revenue Trend: -58.94% |
| 9. EPS Trend: -14.20% |
What is the price of UGI shares?
Over the past week, the price has changed by +3.54%, over one month by +1.44%, over three months by +17.79% and over the past year by +32.83%.
Is UGI a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the UGI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44 | 13.3% |
| Analysts Target Price | 44 | 13.3% |
| ValueRay Target Price | 45 | 15.8% |
UGI Fundamental Data Overview January 20, 2026
P/E Forward = 7.728
P/S = 1.106
P/B = 1.6872
P/EG = 2.65
Revenue TTM = 7.29b USD
EBIT TTM = 1.10b USD
EBITDA TTM = 1.66b USD
Long Term Debt = 6.53b USD (from longTermDebt, last quarter)
Short Term Debt = 486.0m USD (from shortTermDebt, last quarter)
Debt = 7.56b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 6.80b USD (from netDebt column, last quarter)
Enterprise Value = 15.29b USD (8.06b + Debt 7.56b - CCE 335.0m)
Interest Coverage Ratio = 2.67 (Ebit TTM 1.10b / Interest Expense TTM 411.0m)
EV/FCF = 39.19x (Enterprise Value 15.29b / FCF TTM 390.0m)
FCF Yield = 2.55% (FCF TTM 390.0m / Enterprise Value 15.29b)
FCF Margin = 5.35% (FCF TTM 390.0m / Revenue TTM 7.29b)
Net Margin = 9.30% (Net Income TTM 678.0m / Revenue TTM 7.29b)
Gross Margin = 42.12% ((Revenue TTM 7.29b - Cost of Revenue TTM 4.22b) / Revenue TTM)
Gross Margin QoQ = 39.26% (prev 38.62%)
Tobins Q-Ratio = 0.99 (Enterprise Value 15.29b / Total Assets 15.46b)
Interest Expense / Debt = 1.40% (Interest Expense 106.0m / Debt 7.56b)
Taxrate = 2.59% (18.0m / 696.0m)
NOPAT = 1.07b (EBIT 1.10b * (1 - 2.59%))
Current Ratio = 0.89 (Total Current Assets 1.77b / Total Current Liabilities 1.98b)
Debt / Equity = 1.58 (Debt 7.56b / totalStockholderEquity, last quarter 4.78b)
Debt / EBITDA = 4.10 (Net Debt 6.80b / EBITDA 1.66b)
Debt / FCF = 17.43 (Net Debt 6.80b / FCF TTM 390.0m)
Total Stockholder Equity = 4.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.44% (Net Income 678.0m / Total Assets 15.46b)
RoE = 14.09% (Net Income TTM 678.0m / Total Stockholder Equity 4.81b)
RoCE = 9.66% (EBIT 1.10b / Capital Employed (Equity 4.81b + L.T.Debt 6.53b))
RoIC = 8.97% (NOPAT 1.07b / Invested Capital 11.91b)
WACC = 4.53% (E(8.06b)/V(15.62b) * Re(7.49%) + D(7.56b)/V(15.62b) * Rd(1.40%) * (1-Tc(0.03)))
Discount Rate = 7.49% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.34%
[DCF Debug] Terminal Value 84.80% ; FCFF base≈388.4m ; Y1≈337.4m ; Y5≈269.7m
Fair Price DCF = 6.47 (EV 8.19b - Net Debt 6.80b = Equity 1.39b / Shares 214.8m; r=5.90% [WACC]; 5y FCF grow -16.02% → 2.90% )
EPS Correlation: -14.20 | EPS CAGR: -10.17% | SUE: -3.68 | # QB: 0
Revenue Correlation: -58.94 | Revenue CAGR: -19.22% | SUE: -0.52 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.16 | Chg30d=+0.030 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-09-30): EPS=3.13 | Chg30d=-0.103 | Revisions Net=-3 | Growth EPS=-5.7% | Growth Revenue=+20.2%
EPS next Year (2027-09-30): EPS=3.37 | Chg30d=-0.115 | Revisions Net=-2 | Growth EPS=+7.7% | Growth Revenue=-2.2%
Additional Sources for UGI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle